- Home
- HFBL vs RNTX Comparison
HFBL vs RNTX Comparison
Compare HFBL & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HFBL
- RNTX
- Stock Information
- Founded
- HFBL 1924
- RNTX 2001
- Country
- HFBL United States
- RNTX United States
- Employees
- HFBL N/A
- RNTX N/A
- Industry
- HFBL Savings Institutions
- RNTX Biotechnology: Pharmaceutical Preparations
- Sector
- HFBL Finance
- RNTX Health Care
- Exchange
- HFBL Nasdaq
- RNTX Nasdaq
- Market Cap
- HFBL 41.7M
- RNTX 44.2M
- IPO Year
- HFBL N/A
- RNTX N/A
- Fundamental
- Price
- HFBL $12.76
- RNTX $1.72
- Analyst Decision
- HFBL
- RNTX
- Analyst Count
- HFBL 0
- RNTX 0
- Target Price
- HFBL N/A
- RNTX N/A
- AVG Volume (30 Days)
- HFBL 3.0K
- RNTX 27.4K
- Earning Date
- HFBL 05-01-2025
- RNTX 05-19-2025
- Dividend Yield
- HFBL 4.08%
- RNTX N/A
- EPS Growth
- HFBL N/A
- RNTX N/A
- EPS
- HFBL 1.09
- RNTX N/A
- Revenue
- HFBL $20,019,000.00
- RNTX N/A
- Revenue This Year
- HFBL N/A
- RNTX N/A
- Revenue Next Year
- HFBL N/A
- RNTX N/A
- P/E Ratio
- HFBL $11.70
- RNTX N/A
- Revenue Growth
- HFBL N/A
- RNTX N/A
- 52 Week Low
- HFBL $10.60
- RNTX $1.35
- 52 Week High
- HFBL $14.08
- RNTX $4.40
- Technical
- Relative Strength Index (RSI)
- HFBL 40.83
- RNTX N/A
- Support Level
- HFBL $12.86
- RNTX N/A
- Resistance Level
- HFBL $13.39
- RNTX N/A
- Average True Range (ATR)
- HFBL 0.07
- RNTX 0.00
- MACD
- HFBL -0.07
- RNTX 0.00
- Stochastic Oscillator
- HFBL 1.22
- RNTX 0.00
About HFBL Home Federal Bancorp Inc. of Louisiana
Home Federal Bancorp Inc of louisiana operates as a bank holding company. It is a federally chartered stock savings bank, which provides financial services to individuals, corporate entities, and other organizations. Its core activities consist of attracting deposits from the general public and using those funds to originate loans to the residential, commercial and multi-family segments. The company also invests securities held-to-maturity and securities available for sale.
About RNTX Rein Therapeutics Inc. Common Stock
Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03, LTI-01, and others.